Share Market Newspaper

Obesity Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Obesity Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Obesity Clinical Trials analysis report delivers important insights into ongoing research on 80+ pipeline Obesity Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US), September 10, 2026 –

Read Full Article

Gastric Cancer Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight

The Gastric Cancer Clinical Trials analysis report delivers important insights into ongoing research on 200+ pipeline Gastric Cancer Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US), September 10,

Read Full Article

Glioblastoma Clinical Trial Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Glioblastoma clinical trial analysis report delivers important insights into ongoing research on 200+ pipeline Glioblastoma drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US), September 10, 2026 –

Read Full Article

Glioma Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 180+ Leading Players Wheeling the Therapeutics Landscape

The Glioma clinical trial analysis report delivers important insights into ongoing research on 180+ pipeline Glioma drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US), September 10, 2026- DelveInsight’s

Read Full Article

ANCA Vasculitis Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

The ANCA Vasculitis clinical trial analysis report delivers important insights into ongoing research of 12+ pipeline ANCA Vasculitis drugs, clinical

Read Full Article

The PH-ILD Therapeutics Market Size in the 7MM was valued at ~USD 3 billion in 2025 and is projected to expand at a CAGR of 3.9% by 2036

The PH-ILD clinical trial analysis report delivers important insights into ongoing research on multiple pipeline PH-ILD drugs, clinical strategies, upcoming

Read Full Article

COPD Clinical Trial Pipeline Gains Momentum: 65+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Chronic Obstructive Pulmonary Disease clinical trial analysis report delivers important insights into ongoing research of 65+ pipeline Chronic Obstructive

Read Full Article

Eosinophilic Esophagitis Market: Rapid Increment Driven by Innovation by 2036 – DelveInsight | Regeneron, Sanofi, Bristol-Myers Squibb, Ellodi Pharma, AstraZeneca, Allakos, EsoCap AG, Pfizer, Ception

The Key Eosinophilic Esophagitis Companies in the market include – Sanofi/Regeneron Pharmaceuticals, Dr. Falk Pharma GmbH, AstraZeneca and Amgen, Ellodi

Read Full Article

Atopic Dermatitis Market Set for Strong Expansion Through 2036 Amid Rising Investment Interest – DelveInsight | Kymab, BiomX, LEO Pharma, GSK, Arjil Pharma, SCM Lifescience, Sun Pharma, Brickell Bio

The Key Atopic Dermatitis Companies in the market include – Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun

Read Full Article

Alzheimer’s Disease Market Trends, Innovation, and Future Growth Outlook to 2036 – DelveInsight | Alpha Cognition, Biogen, Eisai, Eli Lilly, Otsuka Pharma, Lundbeck, Suven Life Sciences, Roche

The Key Alzheimer’s Disease Companies in the market include – Alpha Cognition, Biogen/Eisai, Eli Lilly, Otsuka Pharma/ Lundbeck, Suven Life

Read Full Article